Artrite reativa pós-COVID-19: relato de caso
Reactive arthritis after COVID-19: a case report
Marcelle Raschik Riche; Henrique Maciel Vieira de Moraes; Wanda Vianna Mury
Resumo
As complicações associadas à COVID-19 incluem insuficiência renal, miocardite, eventos trombóticos e retinite. No entanto, outras manifestações, como a artrite reativa, também parecem estar atreladas a este vírus e precisam ser mais bem investigadas. O caso relatado se refere a uma paciente de 32 anos, do sexo feminino, na cidade do Rio de Janeiro (RJ), que desenvolveu um quadro de artrite reativa após 5 dias da manifestação de sintomas gripais. Foram realizados exames laboratoriais, GeneXpert para COVID-19 e punção do líquido sinovial. Observou-se GeneXpert positivo para COVID-19, aumento nos marcadores inflamatórios, marcadores sorológicos de autoimunidade não reagentes e cultura negativa no líquido sinovial. Esses resultados descartam artrite séptica, bem como artrite reumatoide, passando a ser considerado o quadro de artrite pós-infecciosa decorrente do SARS-CoV-2.
Palavras-chave
Abstract
Complications associated with COVID-19 include renal failure, myocarditis, thrombotic events, and retinitis. However, other manifestations, such as reactive arthritis, also seem to be associated with infection and require further investigation. We report the case of a 32-year-old woman in Rio de Janeiro, RJ who developed reactive arthritis 5 days after the onset of flulike symptoms. Laboratory tests, GeneXpert for COVID-19, and synovial fluid puncture were performed. Positive GeneXpert results for COVID-19, increased inflammatory markers, non-reactive serological markers of autoimmunity, and negative culture in synovial fluid were observed. These results ruled out both septic arthritis and rheumatoid arthritis, leading to a diagnosis of postinfectious arthritis resulting from SARS-CoV-2.
Keywords
References
1. World Health Organization. COVID-19 Public Health Emergency of International Concern (PHEIC). Global research and innovation forum [Internet]. February 2020. Disponível em: https://www.who.int/publications/m/item/covid-19-public-health-emergency-of-international-concern-(pheic)-global-research-and-innovation-forum.
2. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934.
3. Panda SK, Colonna M. Innate Lymphoid Cells in Mucosal Immunity. Front Immunol. 2019 May 7;10:861.
4. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet. 2020 Mar;395(10229):1033‑4.
5. Avelar FG de, Emmerick ICM, Muzy J, Campos MR. Complications of Covid-19: developments for the Unified Health System. Physis: Revista de Saúde Coletiva. 2021;31(1).
6. Kotzias Neto A, Oliveira MA, Stipp WN. Avaliação do tratamento da artrite séptica do quadril. Rev Bras Ortop (São Paulo). 2011;46:14‑20.
7. Goeldner I, Skare TL, Reason ITM, Utiyama SR R. Artrite reumatoide: uma visão atual. J Bras Patol Med Lab. 2011 Oct;47(5):495‑503.
8. Barbosa PJB, Müller RE, Latado AL, Achutti AC, Ramos AIO, Weksler C, et al. Diretrizes Brasileiras para Diagnóstico, Tratamento e Prevenção da Febre Reumática da Sociedade Brasileira de Cardiologia, da Sociedade Brasileira de Pediatria e da Sociedade Brasileira de Reumatologia. Arq Bras Cardiol. 2009;93(3 supl.4):1‑18.
9. Rose CD, Eppes SC. Infection-related arthritis. Rheumatic Disease Clinics of North America. 1997 Aug;23(3):677‑95.
10. Mathew AJ, Ravindran V. Infections and arthritis. Best Pract Res Clin Rheumatol. 2014 Dec;28(6):935‑59.
11. Kocyigit BF, Akyol A. Reactive arthritis after COVID-19: a case-based review. Rheumatol Int. 2021 Nov 22;41(11):2031-9.
12. Gasparotto M, Framba V, Piovella C, Doria A, Iaccarino L. Post-COVID-19 arthritis: a case report and literature review. Clin Rheumatol. 2021 Aug 15;40(8):3357‑62.
13. Ono K, Kishimoto M, Shimasaki T, Uchida H, Kurai D, Deshpande GA, et al. Reactive arthritis after COVID-19 infection. RMD Open. 2020 Aug 6;6(2):e001350.
14. Houshmand H, Abounoori M, Ghaemi R, Bayat S, Houshmand G. Ten-year-old boy with atypical COVID-19 symptom presentation: A case report. Clin Case Rep. 2021 Jan 16;9(1):304-8.
15. Ruiz-Del-Valle V, Sarabia de Ardanaz L, Navidad-Fuentes M, Martín-Martín I, Lobato-Cano R. Reactive arthritis with SARS-COV-2 as a trigger. Reumatol Clin (Engl Ed). 2022;18(8):490-2.
16. Hochberg M, Silman A, Smolen JS, Weinblatt ME, Weisman M. Reumatologia. 6ª ed. Elsevier; 2016; p. 1800.
Submitted date:
10/11/2022
Accepted date:
01/09/2023
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email